Navellier & Associates Inc. Makes New $556,000 Investment in Biogen Inc. (NASDAQ:BIIB)

Navellier & Associates Inc. acquired a new stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,164 shares of the biotechnology company’s stock, valued at approximately $556,000. A number of […]

Related Keywords

United States ,Massachusetts ,Canada ,Germany ,Priya Singhal ,Nasdaq ,Norges Bank ,Massachusetts Financial Services Co ,Securities Exchange Commission ,Navellier Associates Inc ,Pricet Rowe Associates Inc ,Cantor Fitzgerald ,Capital Management ,Royal Bank ,Associates Corp ,Biogen Company Profile ,Needham Company ,Exchange Commission ,Morgan Stanley ,Biogen Inc ,Free Report ,Financial Services ,Trading Down ,Get Free Report ,Visit Holdingschannel ,Biogen Daily ,Biogen ,Nasdaq Biib ,Biib ,Medical ,09062x10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,